Post by
Joemare on Nov 04, 2022 10:13am
Cough up an update soon
Either they are capable of recruting or not. I think that it's time for the elites at THERA cough up their know-how. They can't hide much longer.
a) Clinical trial update, accrual, clearer timelines for data release
Quite simple. Do they have the know-how to sell the clinical trials to investigators and have investigators sell the concept of TH1902 to patients. Not easy for a patient to accept going back to docetaxel when it failed them. That's where THERA's leadership comes into play.
Comment by
Joemare on Nov 04, 2022 10:33am
Yesterday's trading was indeed intriguing. At this point, it's not even POC or P1 results. It's about the konw-how to conduct phase I trial and leadership to recruit patients via their ability to sell the idea to principal investigators of their 'key to cancer' technology.